NasdaqGS - Nasdaq Real Time Price USD
OraSure Technologies, Inc. (OSUR)
At close: 4:00 PM EDT
After hours: 4:02 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
273,535.0000
405,472.0000
387,479.0000
233,674.0000
171,721.0000
Cost of Revenue
145,315.0000
233,820.0000
239,041.0000
116,074.0000
69,853.0000
Gross Profit
128,220.0000
171,652.0000
148,438.0000
117,600.0000
101,868.0000
Operating Expense
109,400.0000
128,238.0000
153,681.0000
129,249.0000
108,144.0000
Operating Income
18,820.0000
43,414.0000
-5,243.0000
-11,649.0000
-6,276.0000
Other Income Expense
12,130.0000
12,844.0000
-10,432.0000
2,357.0000
2,752.0000
Pretax Income
30,950.0000
56,258.0000
-15,675.0000
-9,292.0000
-3,524.0000
Tax Provision
3,357.0000
2,603.0000
1,458.0000
13,706.0000
11,398.0000
Net Income Common Stockholders
27,033.0000
53,655.0000
-17,133.0000
-22,998.0000
-14,922.0000
Diluted NI Available to Com Stockholders
27,033.0000
53,655.0000
-17,133.0000
-22,998.0000
-14,922.0000
Basic EPS
0.36
0.73
-0.25
-0.32
-0.22
Diluted EPS
0.36
0.72
-0.25
-0.32
-0.22
Basic Average Shares
73,802.0000
73,348.0000
72,505.0000
71,981.0000
67,505.0000
Diluted Average Shares
74,395.0000
74,389.0000
72,505.0000
71,981.0000
67,505.0000
Total Operating Income as Reported
4,959.0000
32,684.0000
-22,156.0000
-10,164.0000
-5,177.0000
Total Expenses
254,715.0000
362,058.0000
392,722.0000
245,323.0000
177,997.0000
Net Income from Continuing & Discontinued Operation
27,033.0000
53,655.0000
-17,133.0000
-22,998.0000
-14,922.0000
Normalized Income
39,390.5629
63,891.4200
-3,771.7300
-24,082.0500
-15,724.2700
EBIT
18,820.0000
43,414.0000
-5,243.0000
-11,649.0000
-6,276.0000
EBITDA
30,990.0000
64,353.0000
10,293.0000
846.0000
3,438.0000
Reconciled Cost of Revenue
145,315.0000
233,820.0000
239,041.0000
116,074.0000
69,853.0000
Reconciled Depreciation
12,170.0000
20,939.0000
15,536.0000
12,495.0000
9,714.0000
Net Income from Continuing Operation Net Minority Interest
27,033.0000
53,655.0000
-17,133.0000
-22,998.0000
-14,922.0000
Total Unusual Items Excluding Goodwill
-13,861.0000
-10,730.0000
-16,913.0000
1,485.0000
1,099.0000
Total Unusual Items
-13,861.0000
-10,730.0000
-16,913.0000
1,485.0000
1,099.0000
Normalized EBITDA
44,851.0000
75,083.0000
27,206.0000
-639.0000
2,339.0000
Tax Rate for Calcs
0.0001
0.0000
0.0002
0.0003
0.0003
Tax Effect of Unusual Items
-1,503.4371
-493.5800
-3,551.7300
400.9500
296.7300
12/31/2020 - 11/17/1986
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
INFU InfuSystem Holdings, Inc.
6.39
+3.23%
HBIO Harvard Bioscience, Inc.
2.4000
+2.13%
MMSI Merit Medical Systems, Inc.
98.80
+0.14%
XRAY34.SA DENTSPLY SIRONA Inc.
140.84
+0.44%
56S0.F Sartorius Stedim Biotech S.A.
17.80
+0.56%
AKYA Akoya Biosciences, Inc.
2.7300
-3.02%
SAUHY Straumann Holding AG
13.23
-0.45%
ANGO AngioDynamics, Inc.
6.68
-0.15%
KRMD KORU Medical Systems, Inc.
2.7000
-7.53%
MHUA Meihua International Medical Technologies Co., Ltd.
0.6783
-0.25%